The Report “Blood Culture Test Market Size & Share by Application (Bacteremia, Fungemia), Product (Consumables, Instrument), Method (Automated, Manual), Technology (PCR, Microarray, Proteomic) & End User (Hospital Laboratories, Reference Laboratories) - Global Forecast to 2021”
The overall blood culture test market is projected to reach $4,768.9 million by 2021 from $3, 252.6 million in 2016, at a CAGR of 8.0% during the forecast period.
This report aims to estimate the market size of blood culture test and future growth potential of the global market across different segments such as method, product, technology, application, end user, and region. Factors such as rising aging population, increase in product approvals and launches, growing number of sepsis cases, high incidence of bloodstream infections (BSI), increase in demand for rapid diagnostic techniques, and high prevalence of infectious diseases are driving the market growth.
Download a FREE Pdf Broucher:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159606753
Research Methodology
This study estimates the market size of blood culture test for 2016 and projects its demand till 2021. Top-down and bottom-up approaches were used to estimate and validate the sizes of the global market and various other dependent submarkets of the market.
The key players in the market were identified through secondary research, and their market contributions in the respective regions determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined by secondary sources and verified through primary sources. All possible parameters affecting the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to reach the final quantitative and qualitative data. This data is consolidated and added with detailed inputs and analyses from MarketsandMarkets and presented in this report.
Key players in the blood culture test market include Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (U.S.), Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), Roche Diagnostics (Switzerland), Beckman Coulter (U.S.), Bruker Corporation (U.S.), IRIDICA (U.S.), and T2 Biosystems (U.S.)
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
The overall blood culture test market is projected to reach $4,768.9 million by 2021 from $3, 252.6 million in 2016, at a CAGR of 8.0% during the forecast period.
This report aims to estimate the market size of blood culture test and future growth potential of the global market across different segments such as method, product, technology, application, end user, and region. Factors such as rising aging population, increase in product approvals and launches, growing number of sepsis cases, high incidence of bloodstream infections (BSI), increase in demand for rapid diagnostic techniques, and high prevalence of infectious diseases are driving the market growth.
Download a FREE Pdf Broucher:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159606753
Research Methodology
This study estimates the market size of blood culture test for 2016 and projects its demand till 2021. Top-down and bottom-up approaches were used to estimate and validate the sizes of the global market and various other dependent submarkets of the market.
The key players in the market were identified through secondary research, and their market contributions in the respective regions determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined by secondary sources and verified through primary sources. All possible parameters affecting the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to reach the final quantitative and qualitative data. This data is consolidated and added with detailed inputs and analyses from MarketsandMarkets and presented in this report.
Key players in the blood culture test market include Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (U.S.), Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), Roche Diagnostics (Switzerland), Beckman Coulter (U.S.), Bruker Corporation (U.S.), IRIDICA (U.S.), and T2 Biosystems (U.S.)
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Comments
Post a Comment